Joint Formulary & PAD

Ondansetron hydrochloride - Nausea and vomiting (chemotherapy induced)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important
Oral solution reserved for use when tablets are not suitable. On request from the specialist / Cancer Centre
 

Status 2

Blue
Formulations :
  • Oro-dispersible tablets
  • Orodispersible films
Associated Icons :
SPC
Restrictions / Comments :
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable. On request from the specialist / Cancer Centre
 

Status 3

Red
Formulations :
  • Injection
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ondansetron hydrochloride
Indication :
Nausea and vomiting (chemotherapy induced)
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.